Celebrating 10 Years of Trusted News Discovery
One News Page
> > >

Senate Panel Questions Pharma Execs on Rising Drug Costs

Video Credit: Newsy Studio - Duration: 01:30s - Published < > Embed
Senate Panel Questions Pharma Execs on Rising Drug Costs

Senate Panel Questions Pharma Execs on Rising Drug Costs

Several pharmaceutical executives testified before a Senate committee Monday on the high costs of prescription drugs.


Senate Panel Questions Pharma Execs on Rising Drug Costs

"America has a problem with the high cost of prescription medicines," said Sen.

Chuck Grassley.

Major drug company executives  testified before a Senate panel Tuesday about the rising costs of prescription drugs.  The Senate Finance Committee is looking into the pharmaceutical industry's pricing practices, trying to come up with a way to reduce what consumers pay.  Chairman Sen.

Chuck Grassley  said there needs to be more transparency about how drug prices are set.

"We're all trying to understand the sticker shock that many drugs generate, especially when some of these drugs have been around for a long, long time," he said.  But  pharmaceutical companies  often argue that drug list prices aren't to blame, instead pointing the finger at insurers.  "The central argument is basically from pharma, the fault is always somebody else's.

Health plans are at fault.

The pharmaceutical benefit managers are at fault.

Regulators are at fault," said Sen.

Ron Wyden.

"What we know for certain is the history that pharma CEOs always say that somebody else is at fault."  Health regulators  agree there are  drug price disparities  from country to country, with the U.S. sometimes paying as much as double for certain drugs.  Several  pharmaceutical companies  have either confirmed or planned price hikes this year, despite pressure from the White House to slash costs for consumers.

The Trump administration has  unveiled plans  and  proposals  to rework the U.S. drug pricing system, and  congressional leaders  have recently introduced bills that aim to curb the high-cost trend.  The Senate Finance Committee has also started an investigation  into insulin prices .  Additional reporting from  Newsy affiliate CNN . 

You Might Like

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2019 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.